You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 6,126,971


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,126,971
Title: Stable oral CI-981 formulation and process for preparing same
Abstract:An oral pharmaceutical composition is provided for treating hypercholestereolemia or hyperlipidemia containing an advantageous formulation for stabilizing the HMG-CoA coenzyme A inhibitor, CI-981 Hemi-Calcium, of formula (IA) ##STR1## with effective amounts of calcium carbonate. A method for preparing a CI-981 stabilizing composition is described.
Inventor(s): Mills; Nancy (Mt. Arlington, NJ), Muhammad; Nouman A. (Long Valley, NJ), Weiss; Jay (East Brunswick, NJ), Nesbitt; Russell U. (Somerville, NJ)
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Application Number:08/886,982
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,126,971
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form;

Drugs Protected by US Patent 6,126,971

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,126,971

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 178794 ⤷  Sign Up
Canada 2150372 ⤷  Sign Up
Cyprus 2128 ⤷  Sign Up
Germany 69324504 ⤷  Sign Up
Denmark 0680320 ⤷  Sign Up
European Patent Office 0680320 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.